Search Result

Results for "

cryptosporidium parvum

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ACSL Family (1) Aminoacyl-tRNA Synthetase (1) Bacterial (1) Endogenous Metabolite (3) HDAC (1) Herbicide (1) IMPDH (1) Influenza Virus (1) Isotope-Labeled Compounds (1) Nucleoside Antimetabolite/Analog (1) Parasite (18) PI4K (3) Reference Standards (3)
By Research Areas:	Cancer (1) Cardiovascular Disease (1) Infection (19) Metabolic Disease (3)

Inhibitors & Agonists

Biochemical Assay Reagents

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-N6707

Triacsin C 5+ Cited Publications WS 1228A; FR 900190	ACSL Family Parasite	Infection Cardiovascular Disease
Triacsin C (WS 1228A), is an orally active and intracellular long-chain acyl-CoA synthetases (ACSL) inhibitor, which can be isolated from Streptomyces aureofaciens. Triacsin C inhibits TAG accumulation into lipid droplets (LD) by suppressing ACSL activity . Triacsin C exhibits highly inhibitory effect against rotavirus replication .

HY-N3018

Isomaltose 6-O-α-D-Glucopyranosyl-D-glucose; D-Isomaltose	Endogenous Metabolite Parasite	Infection Metabolic Disease
Isomaltose (6-O-α-D-Glucopyranosyl-D-glucose) is a glucose disaccharide. Isomaltose induces G-CSF secretion via heat-induced oxidative polymerization of glucose groups into high-molecular-weight compounds. Isomaltose modulates cecal bacterial cluster structure in mice. Isomaltose exhibits low glycemic index, slow hydrolysis, and prebiotic properties. Isomaltose reduces in vivo Cryptosporidium parvum colonization in neonatal mice. Isomaltose can be used for the research of Cryptosporidium parvum infection .

HY-W011517

2-Fluoroadenosine 2FA	Parasite	Infection
2-Fluoroadenosine (2FA) is a nucleoside analogue. 2-Fluoroadenosine has antiparasite activity with EC₅₀ value of 0.842 mM for Cryptosporidium parvum. 2-Fluoroadenosine has a highly specific structural basis for MtADK. 2-Fluoroadenosine is commonly used in the study of parasitic conditions .

HY-B1212

Broxyquinoline 2 Publications Verification Dibromohydroxyquinoline; 5,7-Dibromo-8-hydroxyquinoline	Parasite Influenza Virus	Infection
Broxyquinoline (Dibromohydroxyquinoline) is an effective inhibitor of severe fever with thrombocytopenia syndrome virus (SFTSV) with an IC₅₀ of 5.8 µM. Additionally, Broxyquinoline is an inhibitor of CpACBP₁ with an IC₅₀ of 64.9 μM. CpACBP₁ is a fatty acyl-CoA binding protein of Cryptosporidium parvum, thus Broxyquinoline has the potential to inhibit parasite growth. Broxyquinoline shows promise for research in the field of infectious diseases .

HY-126130

LysRs-IN-2 1 Publications Verification	Aminoacyl-tRNA Synthetase	Infection
LysRs-IN-2 is a lysyl-tRNA synthetase (KRS) inhibitor with IC₅₀s of 0.015 μM and 0.13 μM for Plasmodium falciparum lysyl-tRNA synthetase (PfKRS) and Cryptosporidium parvum lysyl-tRNA synthetase (CpKRS), respectively .

HY-114866

Eritadenine 1 Publications Verification Lentinacin; D-Eritadenine; Lentysine	Parasite Nucleoside Antimetabolite/Analog	Infection
Eritadenine (D-Eritadenine) is a potent AdoHcyase inhibitor, with an IC₅₀ value of 7 nM. Eritadenine is also an acyclic sugar adenosine analogue. Eritadenine exhibits an inhibitory effect on the growth of Cryptosporidium parvum, with a MIC₅₀ of 3 μM. Eritadenine can be used in the research of colorectal adenocarcinoma .

HY-156685

EDI048	PI4K Parasite	Infection Metabolic Disease Cancer
EDI048 is an orally active, gut-restricted parasiticidal agent. EDI048 specifically binds to the ATP-binding site of Cryptosporidium phosphatidylinositol 4-kinase (CpPI (4) K), blocks parasite membrane biogenesis, arrests the pathogen at the schizont stage, and thus irreversibly clears the infection. EDI048 is rapidly converted to an inactive carboxylic acid metabolite via hepatic first-pass metabolism, with extremely low systemic exposure, good safety profile, and no cardiotoxicity, genotoxicity or off-target effects. EDI048 is used in studies of intestinal cryptosporidiosis in children .

HY-B0956A

Paromomycin Aminosidine	Bacterial Parasite Endogenous Metabolite	Infection
Paromomycin (Aminosidine) is an orally active broad-spectrum aminoglycoside aminocyclitol. Paromomycin is produced by Streptomyces riomosus var. Paromomycinus. Paromomycin binding induces local conformational changes in the 16S rRNA A-site. Paromomycin exhibits inhibitory activity against C. parvum. Paromomycin can be used in research related to leishmaniasis, amoebiasis and cryptosporidiosis .

HY-103583

KDU731	PI4K Parasite	Infection
KDU731, an orally active C. parvum PI4K inhibitor with an IC₅₀ value of 25 nM, blocks Cryptosporidium infection in vitro and in vivo . KDU731 is a promising agent candidate for the treatment of diarrhea caused by Cryptosporidium and meets a broad range of safety .

HY-128214

IMPDH-IN-3	IMPDH Parasite	Infection
IMPDH-IN-3 (Compound C67) is an inhibitor of C. parvum IMPDH (CpIMPDH) with an IC₅₀ of 35 nM. IMPDH-IN-3 can be used in the research of anti-Cryptosporidium drugs .

HY-W011517R

2-Fluoroadenosine (Standard) 2FA (Standard)	Reference Standards Parasite	Infection
2-Fluoroadenosine (2FA) is a nucleoside analogue. 2-Fluoroadenosine has antiparasite activity with EC₅₀ value of 0.842 mM for Cryptosporidium parvum. 2-Fluoroadenosine has a highly specific structural basis for MtADK. 2-Fluoroadenosine is commonly used in the study of parasitic conditions .

HY-120489

A110	Parasite	Infection
A110 is the inhibitor for Cryptosporidium parvum inosine monophosphate dehydrogenase (CpIMPDH). A110 inhibits CpIMPDH in Toxoplasma gondii with IC₅₀ of 18 nM. A110 exhibits pro-parasitic efficacy and cause parasitemia .

HY-136307S

Tizoxanide-d4 glucuronide	Isotope-Labeled Compounds Parasite	Infection
Tizoxanide-d₄ glucuronide is the deuterium labeled Tizoxanide glucuronide. Tizoxanide glucuronide is the metabolite of Nitazoxanide (HY-B0217) and is cell-permeable to inhibit asexual and sexual stages development of parasite C. parvum .

HY-165555

MMV665917	Parasite	Infection
MMV665917 is an orally active piperazine derivative with anti-Cryptosporidium parvum activity with an EC₉₀ of 15 μM. MMV665917 significantly reduces the parasite load in a porcine model infected with C. hominis, decreases ovarian excretion, alleviates diarrhea symptoms and reduces intestinal mucosal damage. MMV665917 can be used for research on Cryptosporidium parvum disease .

HY-118421

Nullscript	Parasite HDAC	Infection
Nullscript is a negative control for Scriptaid. Nullscript is a known inactive analog of Scriptaid . Scriptaid is a representative HDAC inhibitor . Nullscript inhibits Cryptosporidium (C. parvum) growth with the IC₅₀ value of 2.1 μM .

HY-158776

SLU-10482	Parasite	Infection
SLU-10482 is an orally active anti-parasitic agent, that inhibits Cryptosporidium parvum with an IC₅₀ of 0.0687 μM. SLU-10482 exhibits anti-infective efficacy in C. parvum infected mice with an AC₅₀ of 0.0686 μM .

HY-N3018R

Isomaltose (Standard) 6-O-α-D-Glucopyranosyl-D-glucose (Standard); D-Isomaltose (Standard)	Reference Standards Endogenous Metabolite Parasite	Infection Metabolic Disease
Isomaltose (Standard) is the analytical standard of Isomaltose (HY-N3018). This product is intended for research and analytical applications. Isomaltose induces G-CSF secretion via heat-induced oxidative polymerization of glucose groups into high-molecular-weight compounds. Isomaltose modulates cecal bacterial cluster structure in mice. Isomaltose exhibits low glycemic index, slow hydrolysis, and prebiotic properties. Isomaltose reduces in vivo Cryptosporidium parvum colonization in neonatal mice. Isomaltose can be used for the research of Cryptosporidium parvum infection .

HY-W714201

Nitralin	Herbicide Parasite	Infection
Nitralin is a dinitroaniline herbicide. Nitralin exhibits inhibitory activity against Cryptosporidium parvum, with a IC₅₀ of 4.5 µM .

HY-103583R

KDU731 (Standard)	Reference Standards PI4K Parasite	Infection
KDU731 (Standard) is the analytical standard of KDU731 (HY-103583). This product is intended for research and analytical applications. KDU731, an orally active C. parvum PI4K inhibitor with an IC₅₀ value of 25 nM, blocks Cryptosporidium infection in vitro and in vivo . KDU731 is a promising agent candidate for the treatment of diarrhea caused by Cryptosporidium and meets a broad range of safety .

Cat. No.	Product Name	Type

HY-W011517

2-Fluoroadenosine 2FA	Biochemical Assay Reagents
2-Fluoroadenosine (2FA) is a nucleoside analogue. 2-Fluoroadenosine has antiparasite activity with EC₅₀ value of 0.842 mM for Cryptosporidium parvum. 2-Fluoroadenosine has a highly specific structural basis for MtADK. 2-Fluoroadenosine is commonly used in the study of parasitic conditions .

HY-W011517R

2-Fluoroadenosine (Standard) 2FA (Standard)	Biochemical Assay Reagents
2-Fluoroadenosine (2FA) is a nucleoside analogue. 2-Fluoroadenosine has antiparasite activity with EC₅₀ value of 0.842 mM for Cryptosporidium parvum. 2-Fluoroadenosine has a highly specific structural basis for MtADK. 2-Fluoroadenosine is commonly used in the study of parasitic conditions .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-N6707

Triacsin C 5+ Cited Publications WS 1228A; FR 900190	Infection Structural Classification Microorganisms Classification of Application Fields Ketones, Aldehydes, Acids Disease Research Fields Source Classification	ACSL Family Parasite
Triacsin C (WS 1228A), is an orally active and intracellular long-chain acyl-CoA synthetases (ACSL) inhibitor, which can be isolated from Streptomyces aureofaciens. Triacsin C inhibits TAG accumulation into lipid droplets (LD) by suppressing ACSL activity . Triacsin C exhibits highly inhibitory effect against rotavirus replication .

HY-N3018

Isomaltose 6-O-α-D-Glucopyranosyl-D-glucose; D-Isomaltose	Structural Classification Human Gut Microbiota Metabolites Polysaccharides Classification of Application Fields Metabolic Disease Endogenous metabolite Disease Research Fields Saccharides Source Classification	Endogenous Metabolite Parasite
Isomaltose (6-O-α-D-Glucopyranosyl-D-glucose) is a glucose disaccharide. Isomaltose induces G-CSF secretion via heat-induced oxidative polymerization of glucose groups into high-molecular-weight compounds. Isomaltose modulates cecal bacterial cluster structure in mice. Isomaltose exhibits low glycemic index, slow hydrolysis, and prebiotic properties. Isomaltose reduces in vivo Cryptosporidium parvum colonization in neonatal mice. Isomaltose can be used for the research of Cryptosporidium parvum infection .

HY-B0956A

Paromomycin Aminosidine	Structural Classification Microorganisms Antibiotics Other Antibiotics Source Classification	Bacterial Parasite Endogenous Metabolite
Paromomycin (Aminosidine) is an orally active broad-spectrum aminoglycoside aminocyclitol. Paromomycin is produced by Streptomyces riomosus var. Paromomycinus. Paromomycin binding induces local conformational changes in the 16S rRNA A-site. Paromomycin exhibits inhibitory activity against C. parvum. Paromomycin can be used in research related to leishmaniasis, amoebiasis and cryptosporidiosis .

HY-N3018R

Isomaltose (Standard) 6-O-α-D-Glucopyranosyl-D-glucose (Standard); D-Isomaltose (Standard)	Structural Classification Human Gut Microbiota Metabolites Polysaccharides Microorganisms Endogenous metabolite Saccharides Source Classification	Reference Standards Endogenous Metabolite Parasite
Isomaltose (Standard) is the analytical standard of Isomaltose (HY-N3018). This product is intended for research and analytical applications. Isomaltose induces G-CSF secretion via heat-induced oxidative polymerization of glucose groups into high-molecular-weight compounds. Isomaltose modulates cecal bacterial cluster structure in mice. Isomaltose exhibits low glycemic index, slow hydrolysis, and prebiotic properties. Isomaltose reduces in vivo Cryptosporidium parvum colonization in neonatal mice. Isomaltose can be used for the research of Cryptosporidium parvum infection .

Cat. No.	Product Name	Chemical Structure

HY-136307S

Tizoxanide-d4 glucuronide
Tizoxanide-d₄ glucuronide is the deuterium labeled Tizoxanide glucuronide. Tizoxanide glucuronide is the metabolite of Nitazoxanide (HY-B0217) and is cell-permeable to inhibit asexual and sexual stages development of parasite C. parvum .

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent:

Name
Email *

	Sorry, but the email address you supplied was invalid.

cryptosporidium parvum

Inhibitors & Agonists

Biochemical Assay Reagents

NaturalProducts

Isotope-Labeled Compounds

Natural
Products